355 reports of this reaction
3.5% of all ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE reports
#2 most reported adverse reaction
NAUSEA is the #2 most commonly reported adverse reaction for ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE, manufactured by Kenvue Brands LLC. There are 355 FDA adverse event reports linking ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE to NAUSEA. This represents approximately 3.5% of all 10,191 adverse event reports for this drug.
Patients taking ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 355 FDA reports for ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.5% of all adverse event reports for ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience nausea while taking ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.